Secondary metabolite
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
 |
It has been suggested that this article or section be merged into natural product. (Discuss) |
Secondary metabolites are organic compounds that are not directly involved in the normal growth, development or reproduction of organisms. Unlike primary metabolites, absence of secondary metabolities results not in immediate death, but in long-term impairment of the organism's survivability/fecundity, or aesthetics, or may perhaps, result in no significant change at all. Secondary metabolites are often restricted to a narrow set of species within a phylogenetic group.
The function or importance of these compounds to the organism is usually of an ecological nature as they are used as defenses against predators, parasites and diseases, for interspecies competition, and to facilitate the reproductive processes (coloring agents, attractive smells, etc). Since these compounds are usually restricted to a much more limited group of organisms, they have long been of prime importance in taxonomic research.
Biomining is the process of seeking organisms for the purpose of exploiting their natural products for drug or other technological development directly, or as an inspiration for unnatural products. This will concern secondary metabolites in plants, bacteria, fungi and many marine organisms (sponges, tunicates, corals, snails). In some cases, higher organisms will host a microorganism which is the actual producer of the product in question, as part of a symbiotic relationship. Most of the secondary metabolites of interest to man fit into the following categories, and some fall into more than one:
These categories are broad categories which classify secondary metabolites based on their biosynthetic origin. Since secondary metabolites are often created by modified primary metabolite synthases, or "borrow" substrates of primary metabolite origin, these categories should not be interpreted as saying that all molecules in the category are secondary metabolites (for example the steroid category), but rather that there are secondary metabolites in these categories.
Small "small molecules"
- Alkaloids (usually a small, heavily derivatized amino acid):
- Hyoscyamine, present in Datura stramonium
- Atropine, present in Atropa belladonna, Deadly nightshade
- Cocaine, present in Erythroxylon coca the Coca plant
- Codeine and Morphine, present in Papaver somniferum, the opium poppy
- Tetrodotoxin, a microbial product in Fugu and some salamanders
- Terpenoids (come from semiterpene oligomerization):
- Azadirachtin A, (Neem tree)
- Artemisinin, present in Artemisia annua Chinese wormwood
- tetrahydrocannabinol, present in cannabis sativa
- Steroids (Terpenes with a particular ring structure)
- Saponins (plant steroids, often glycosylated)
- Glycosides (heavily modified sugar molecules):
- Phenols:
- Phenazines:
- Pyocyanin
- Phenazine-1-carboxylic acid (and derivatives)
Big "small molecules", produced by large, modular, "molecular factories".
- Polyketides:
- Fatty acid synthase products :
- FR-900848
- U-106305
- phloroglucinols
- Nonribosomal peptides:
- Hybrids of the above three:
Non-"small molecules" - DNA, RNA, ribosome, or polysaccharide "classical" biopolymers.
- Ribosomal peptides:
- Microcin-J25
See also
Secondary metabolismde:Sekundäre Pflanzenstoffefr:Métabolite secondaire no:Sekundær metabolitt sk:Sekundárny metabolit
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
